Researcher Fired Over Cell Fiasco
By Associated Press,
Associated Press
| 03. 21. 2006
SEOUL _ The scientist who stunned the medical world with claims that he had created the first cloned human embryos and extracted stem cells from them _ research later found to have been faked _ was fired Monday by South Korea's most prestigious university.
Seoul National University decided to dismiss Hwang Woo-suk after a disciplinary meeting, saying he and his co-workers caused the school to lose honor. Six other professors who worked with Hwang were either suspended or had their salaries cut, the school said.
Last month, the school suspended Hwang, 53, from teaching and conducting research as an interim disciplinary measure, but he had remained a professor.
"The professors fundamentally abandoned honesty and sincerity _ and caused the fall in the school's honor and the country's international confidence," the university said in a statement Monday.
Byun Chang-ku, dean of the school's academic affairs, said the committee had decided to fire Hwang because he "took overall responsibility as the lead author and played a leading role in writing the papers with fake facts and data."
Hwang rarely appears in public...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...